dinutuximab beta
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for dinutuximab beta, covering 2024-10-04 to 2026-01-06. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children [Phase 2]